Back

Correction to: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation

European Heart Journal - Cardiovascular Pharmacotherapy

28 July 2026
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Hypertension and urate
30 August 2025
thumbnail
Congress Presentation
Meta-analysis assessing cardiovascular outcomes with febuxostat versus allopurinol for patients with gout
27 August 2021
thumbnail
Congress Presentation
ARG1 is associated with reduced cardiometabolic risk in patients with rheumatoid arthritis: a cis-instrument Mendelian randomisation proteomic analysis
28 August 2026
thumbnail
Congress Presentation
Myocardial tissue alterations in patients with alkaptonuria
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources